Outcomes of black and white men with prostate cancer in an equal access healthcare setting

Share :
Published: 5 Feb 2021
Views: 1207
Kenrick Ng - Senior Specialist Registrar in Medical Oncology, UCL Hospitals, London, UK

Kenrick Ng speaks to ecancer about the findings of a 20-year retrospective analysis investigating the overall survival of black and white men with metastatic castration-resistant prostate cancer.

He reports that while the incidence of prostate cancer in black men is higher, they may do better than their white counterparts if equal access to healthcare is available. It was also observed that black men may benefit more from hormone-based therapy.

Kenrick notes that when interpreting the results, it's important to keep in mind that the study used data from an equal access healthcare setting in East London.